Consistent with this notion, AdicerKO mice do not benefit from some of the classic metabolic outcomes of DR, such as increased insulin sensitivity and decreased inflammation, and have accelerated age-dependent insulin resistance and premature mortality. Here, INS is linked to Insulin resistance.